• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
  • AUXILIARY MENU
Menu
GOVPH
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

DOST - Health Technology Assessment Official Logo
Republic of the Philippines
DOST - Health Technology Assessment

Philippine Standard Time:

[Department Circular No. 2021- 0273] HTAC Issuance on Acceptance and processing of Health Technologies under Monitored Release with Phase IV Trial Data

Posted on July 20, 2021

Evidence brief for 10 July to 16 July 2021

Posted on July 16, 2021

For the period of  10 July to 16 July 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 10 July to 16 July 2021

Preliminary Recommendation on Two-Dose Inactivated Polio Vaccine (IPV)

Posted on July 13, 2021

Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 28 July 2021.) Document Preview:

Evidence brief for 05 July to 09 July 2021

Posted on July 9, 2021

For the period of  05 July to 09 July 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 05 July to 09 July 2021

[Department Memorandum No. 2021- 0294] Non-inclusion of Lapatinib in the Philippine National Formulary

Posted on July 5, 2021

Post navigation

← Older posts
Newer posts →